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ferences in QTc intewls between M and F OHT recipients were also compared. 
RESULTS: In the early post OHT period, there was a significant decrease in the QTc 
interval for the F to M transplantation subgroup which persisted throughout follow-up. 
QTc Changes Following Transplant&on 
Group (Donor to Recipient) 2 days 1 week 1 month 1 year 
MtoM -15*66 2+38 -6*46 1*40 
MiuF 2252 -4i27 0+35 8*28 
F to F -15*49 -6+33 -37+1* &31 
F to M -42r36 -23*18 -16212’ -24*22’ 
* = p &amp;amp:lt; 0.05 for change in QTc 
When comparing the QTC among M and F recipients, there was no gender difference in 
the QTc interval at early follow-up (419+27 YS 420 +23 for M vs Fat 1 week; 416231 vs 
415a23 at 1 month), but a significant 
(p&amp;amp;amp;amp;amp;amp;amp;amp:amp;lt;O.O5) difference at late follow-up 
(417t26 vs 432+26 for M YS Fat 1 year; 429*30 vs 450*25 at >2 year follow-up). CON- 
CLUSIONS: Gender related QTc changes are evident both immediately and late after 
OHT. These effects are most consistent with a hormonal etiology and probably not due to 
autonomic influences. 
2:30 pm 
821-3 SCNSA Mutations in the S5-S6 Region Cause Srugada 
Syndrome and Cardiac Conduction Disturbances 
Hideki ltoh Masami Shimizu, Hiroshi Mabuchi, Graduate School of Medical Science, -I 
Kanazawa University, Kanazawa, Japan 
Background: The SCNBA gene encoding the alpha subunit of the human cardiac sodium 
channel plays a key role in cardiac electrophysiology. Mutations in SCN5A lead to a wide 
variety of phenotypes, including long QT syndrome, Brugada syndrome, and isolated 
progressive cardiac conduction defects. Clinically. there appears to be some overlap 
among these syndromes, as all are associated with a relatively high incidence of noctur- 
nal sudden cardiac death without prior symptoms. 
Methods: DNA was isolated from peripheral white blood cells of 40 patients with Brugada 
syndrome in Japan and analyzed SCNBA mutations by PCR-SSCP and direct sequence 
methods. 
Results: We detected 2 point mutations in the SCN5A gene (Arg282His and Asn406Ser). 
These mutations was not detected in 200 chromosomes of normal controls and sug- 
gested as disease causing mutations. In a 51 year-old man with frequent nocturnal poly- 
morphic ventricular tachycardra, we found the Arg282His mutation in the SS-pore region 
of domain I. He had a 36-year-old brother who suffered sudden death. We analyzed 5 
family members and detected 3 of the Arg282His mutation carriers and 2 noncarriers. 
The 2 noncarriers had neither aborted sudden death nor electrocardiographic changes. 
Two of the mutation carriers, excluding the proband, had no syncope or ventricular fibril- 
lation. All 3 mutation carriers had ST-segment elevations in leads Vl to V2N3. Two of 
the mutation carriers, excluding the proband. had ST-segment elevations and a widened 
QRS complex. The PO and QT intervals in all of the patients with the Arg282His mutation 
were normal. In a 67 year-old man with asymptomatic Brugada syndrome, we found the 
Asn406Ser mutation in the S6 segment of domain I. He had 21 year-old father and 27 
year-old cousin with sudden death. Proband with the Asn406Ser mutation had not only 
ST-segment elevation but bradycardia, first degree of atrioventricular block, and prolon- 
gation of the QRS width. 
Conclusions: We suggested SCN5A mutations in the S5-S6 region cause both Brugada 
syndrome and cardiac conduction disturbances. Both mutations are located in important 
sites in the Sbpore or S6 segment that confer ion selectivity and mutations might cause 
serious clinical phenotypes. 
2:45 p.m. 
821-4 Cardiac Autonomic Modulation by Estrogen in Female 
Mice Undergoing Ambulatory Monitoring and In Yivo 
Electrophysiologic Testing 
Samir Saba, Vladimir Shusterman, lrmute Usiene, Barry London, University of 
Pittsburgh, Pittsburgh, PA 
Introduction: Estrogen is an impoltant modulator of cardiovascular risk, but its mecha- 
nism of action is not fully understood. In this study, we investigated the effect of ovariec- 
tomy and its timing on the cardiac electrophysiology (EP) in female mice, with and 
without autonomic blockade. Methods: Thirty female mice (age 16.6+ 3.1 weeks) “nder- 
went blinded in viva EP testing before and 10 minutes after administration of atropine 
(0.5 mglkg, IP) and propranolol (1 mglkg, IP). Fifteen mice were ovariectomized pre- 
puberty (PRE) and 10 post-puberty (POST), 2 weeks prior to EP testing. Five sham-oper- 
ated female mice (F) served as controls. A subset of 19 mice (5 PRE, 3 POST, and 5 F) 
underwent 24.hour ambulatory monitoring prior to the EP testing. Uteri from all mice 
were surgically removed and weighed. Results: With ambulatory monitoring, the aver- 
age (668+ 28 versus 769* 52 b/min, p=O.OOS) and minimum (485* 47 versus 587+ 53 b/ 
mm, p=O.OZ) heart rates were significantly slower in the ovariectomized mice (PRE and 
POST groups) compared to the F group. At baseline EP testing, there were no significant 
differences between the ovariectomized and intact mice in any of the measured parame- 
ters. With autonomic blockade, the F group had a significantly larger change (A ) in the 
atrioventricular (AV) nodal Wenckebach (AVW) periodicity (A AVW = 11.3* 2.9 versus 
2.1 t 7.3 ms, p=O.O5) and functional refractory period (A FRP = 11.3+ 2.1 versus 1.25* 
6.8 ms, p=O.O2) compared to the ovariectomized mice. These results were not altered by 
the time of ovarlectomy (PRE versus POST groups). The weights of the uteri were signif- 
icantly different among the 3 groups (14.3t 6.7 mg, 23.5* 10.6 mg, 68.5+ 17.7 mg for the 
PRE, POST and F groups respectively, ~~0.05 for all comparisons). Conclusion: Our 
results suggest that estrogen modulates the autonomic inputs into the murine sinus and 
AV nodes. Low estrogen states, regardless of the time of ovariectomy, decrease the 
autonomic influence on the heart. These findings, if replicated in humans, might underlie 
the observed clustering of certain arrhythmias around menstruation and their higher inci- 
dence in men and post-menopausal women. 
3:00 p.m. 
821-5 Validation of Electrocardiogram Criteria for Pulmonary 
Hypertension 
Khalid Al-Naamani Thao Huynh, S. Andrew, McGill University Health Center, Montreal, 
PQ, Canada 
Background Measurement of right ventricle systolic pressure (RVSP) by PD-echocar- 
diography (echo) had been shown to have good correlation with value obtained by car- 
diac catheterization. We aimed to validate the sensitivity, specificity and predictive values 
of electrocardiography in patients with elevated RSVP diagnosed by PD-echocardio- 
graphy. 
Methods We analyzed all patients who had echo and EKG, withm a l-month interval, at 
our institution during 2000-2001. The following criteria were studied. 
7) R wave in V1>7mm or2)R wave in V5<5mm or3) R wave in lead 1<2mm or 4)RSr in 
Vl with R>l Omm w 5) S wave in V6>7mm or6) S wave in V1<2mm or 7) R/S in Vl >l cy 
8) WS in V6<1; 3 RVl+SVS or 10) SV6810 mmor RAD>llOor qR in Vl. Significant pul- 
monary hyperlension was defined as RVSP240 mm Hg by 2-D Echo and no pulmonary 
stenosis. 
Results There were 365 patients with EKG and echo within a l-month interval. We 
excluded all patients with paced rhythm and poor EKG quality. The above criteria have 
very poor sensitivity (0.0% to 13%), negative predictive values (24% to 36%). They had 
excellent specificity (92% to 100%) with positive predictive values ranging from 64% to 
100%. 
Although highly specific, these criteria have poor sensitivity and negative predictive val- 
“es. 
Conclusion The currently available EKG criteria are poorly 
sensitive for significant pulmonary hypertension. New EKG 
criteria with better sensitivity should be developed. 
Sensitivity % Specificity % + Predictive Value% - Predictive Value % Accuracy % 
2.55 96.7 63.6 24.5 25.8 
13.45 93.3 30.8 26.3 32.2 
8.0 94.4 61.5 25.1 29.3 
0.01 100 100 24.8 25.2 
1.8 98.9 83.3 24.8 25.7 
4.0 100 100 25.4 27.7 
7.0 3.3 86.4 35.0 29.0 
2.9 2.2 60.0 24.8 26.3 
1.1 2.2 60.0 24.4 24.9 
8.0 3.3 88.0 25.6 29.9 
5.6 3.3 84.2 35.4 28.2 
10.2 7.8 80.0 25.2 30.4 
3:15 p.m. 
621-6 Increased Levels of High-Sensitivity C-Reactive Protein 
Are Associated With a Longer QTc Interval in 
Apparently Healthy Subjects 
Aria P. Yazdanbakhsh, Bojan Vrtovec, Branislav Radovancevic. Todd T. Schlegel. NASA 
Johnson Space Center, Houston, TX 
Background. QTc interval prolongation is associated with an increased risk of cardio- 
vascular moltality in apparently healthy individuals. Furthermore, healthy subjects with 
increased levels of high-sensitivity C-reactive protein (hsCRP) are at a higher risk of car- 
diovascular disease. Whether increased levels of hsCRP are associated with a longer 
QTc intswal has not yet been studied. Methods. In 110 (56 male/ 54 female) healthy vol- 
unteers with a mean age of 36 + 11 (range 20-65) years, mean QT interval was mea- 
sured from a standard 12-lead ECG and QTc interval duration was calculated with the 
Bazett formula. At the time of ECG recordings, plasma levels of hsCRP were measured 
using the Kaimaya assay. Cardiovascular risk stratification included assessment for the 
presence of hypertension, smoking, and diabetes mellitus; and measurement of serum 
cholesterol, LDL, and HDL levels. The lo-year coronary disease risk was calculated 
according to Framingham risk estimates. Results. The overall mean QTc intewal was 
399 + 25 ms (range: 321 - 469 ms), and the mean hsCRP level was 0.195 + 0.364 mg/dl 
(range: 0.002 - 2.517 mg/dl). Out of 110 subjects, 48 (43%) had an hsCRP level > 0.12 
mg/dl. and 62 (57%) had an hsCRP level < 0.12 mg/dl. The subjects with hsCRP > 0.12 
mg/dl had a significantly longer QTc interval than those with hsCRP < 0.12 mg/dl (405 f 
23 ms vs. 392 + 25 ms, p=O.O18). In multivariate analysis. hsCRP level > 0.12 mg/dl was 
associated with significantly longer QTc intewal (p=O.O47). No other differences in car- 
diovascular risk factors between the high-hsCRP and low-hsCRP groups were found. 
